Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
370 Tumor-wide neoantigen-specific T-cells infiltrating mutant IDH1 low-grade gliomas and persisting in peripheral blood allow for personalized TCR-based immunotherapies
Compose a Response to This Article
Other responses
No responses have been published for this article.
